Elisa M Noll
Overview
Explore the profile of Elisa M Noll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muzumdar M, Chen P, Dorans K, Chung K, Bhutkar A, Hong E, et al.
Nat Commun
. 2017 Oct;
8(1):1090.
PMID: 29061961
Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (PDAC), an aggressive malignancy with few effective therapeutic options. Despite efforts to develop KRAS-targeted drugs, the absolute...
2.
Dumas M, Rothwell A, Hoyles L, Aranias T, Chilloux J, Calderari S, et al.
Cell Rep
. 2017 Jul;
20(1):136-148.
PMID: 28683308
The influence of the gut microbiome on metabolic and behavioral traits is widely accepted, though the microbiome-derived metabolites involved remain unclear. We carried out untargeted urine H-NMR spectroscopy-based metabolic phenotyping...
3.
Kuhlmann L, Nadler W, Kerner A, Hanke S, Noll E, Eisen C, et al.
Pancreas
. 2016 Nov;
46(3):311-322.
PMID: 27846146
Objectives: Pancreatic ductal adenocarcinoma (PDAC) has been subclassified into 3 molecular subtypes: classical, quasi-mesenchymal, and exocrine-like. These subtypes exhibit differences in patient survival and drug resistance to conventional therapies. The...
4.
Noll E, Eisen C, Stenzinger A, Espinet E, Muckenhuber A, Klein C, et al.
Nat Med
. 2016 Feb;
22(3):278-87.
PMID: 26855150
Although subtypes of pancreatic ductal adenocarcinoma (PDAC) have been described, this malignancy is clinically still treated as a single disease. Here we present patient-derived models representing the full spectrum of...
5.
Dietlein F, Kalb B, Jokic M, Noll E, Strong A, Tharun L, et al.
Cell
. 2015 Jul;
162(1):146-59.
PMID: 26140595
KRAS is one of the most frequently mutated oncogenes in human cancer. Despite substantial efforts, no clinically applicable strategy has yet been developed to effectively treat KRAS-mutant tumors. Here, we...
6.
Johnson J, Folestad E, Rowley J, Noll E, Walker S, Lloyd C, et al.
Am J Physiol Lung Cell Mol Physiol
. 2015 Feb;
308(7):L658-71.
PMID: 25637607
Myofibroblast accumulation, subepithelial fibrosis, and vascular remodeling are complicating features of chronic asthma, but the mechanisms are not clear. Platelet-derived growth factors (PDGFs) regulate the fate and function of various...